Serum vitamin D and hippocampal gray matter volume in schizophrenia
Introduction
Disparate lines of evidence have implicated vitamin D in the pathogenesis of schizophrenia. Infant cohort studies have revealed elevated risk for schizophrenia in infants with deficient vitamin D (McGrath et al., 2010) and reduced risk in those who had received supplementation (McGrath et al., 2004). Deficient serum levels of vitamin D have been observed in patients with first episode psychosis (Graham et al., 2014) as well as in patients with chronic schizophrenia (Humble et al., 2010). A recent meta-analysis on the relationship between vitamin D and psychosis reported a moderately significant reduction in serum levels of vitamin D in schizophrenia patients compared with healthy controls and a trend for lower levels compared with other psychoses (Belvederi Murri et al., 2013).
Following the discovery of vitamin D receptors (VDRs) in neurons and glial cells (Garcion et al., 2002), studies have increasingly demonstrated the importance of vitamin D in early brain development as well as in facilitating optimal brain function (Eyles et al., 2003). Vitamin D can cross the blood–brain barrier and stimulate a broad range of functions by binding to VDRs (Kalueff et al., 2006). The action of vitamin D in the brain is largely considered to be neuroprotective (Garcion et al., 2002). It is reported to be involved in the biosynthesis of neurotransmitters and neurotrophic factors like brain-derived neurotrophic factor (BDNF) (Kiraly et al., 2006). It is also implicated in the reduction of free radicals and reactive oxygen species, and hence confers neuroprotection (Garcion et al., 1997, Wang et al., 2001). Since deficient BDNF (Kalmady et al., 2013) and increased oxidative stress (Wu et al., 2013) have been associated with schizophrenia, these effects mediated by vitamin D through VDRs could be critical in this disorder.
Interestingly, both deficient BDNF (Erickson et al., 2010) and as excessive oxidative stress (Wang and Michaelis, 2010) can result in abnormalities of the hippocampus – a brain region that hypothetically plays a critical role in schizophrenia pathogenesis (Heckers and Konradi, 2010). Hippocampal abnormalities in schizophrenia manifest in the form of smaller hippocampal volume, altered number of neurons, reduced functional activity and abnormal functioning of genes expressed by the hippocampus (Harrison, 2004, Heckers and Konradi, 2010). Among these, smaller hippocampal volume in schizophrenia is a well-replicated finding in many studies (Steen et al., 2006, Heckers and Konradi, 2010). More importantly, the hippocampus is one of the brain regions with maximal concentrations of VDRs (Eyles et al., 2005); vitamin D has been shown to play a critical role in hippocampal cell survival through its neuroprotective effects (Langub et al., 2001).
All of these observations suggest that vitamin D deficiency in schizophrenia might be associated with hippocampal abnormalities. To date, no study has looked into the association between serum vitamin D and hippocampal volume in schizophrenia. In this study therefore, we examined the association between serum vitamin D level and hippocampal gray matter (GM) volume in antipsychotic-naïve or anti-sychotic-free schizophrenia patients. We hypothesized that hippocampal GM volume would positively correlate with serum vitamin D levels in schizophrenia patients.
Section snippets
Clinical profile
Schizophrenia patients (n=35; mean age=32.14±6.6; mean years of education=9.91±4.23; 20 men) attending the clinical services of the National Institute of Mental Health and Neurosciences (India) participated in the study. They were either antipsychotic-naïve (n=25, i.e., never treated with any psychotropic medications including antipsychotics) or antipsychotic-free (n=10, not having been treated with oral medication for at least 6 weeks or with depot antipsychotics for 3 months). Diagnosis of
Results
The Serum vitamin D (mean±SD) level determined in the study subjects was 14.5±5.7 ng/ml, with 29 patients having deficient levels (<20 ng/ml) and 5 insufficient levels (20–29 ng/ml) relative to control norms (Harinarayan et al., 2008, Holick et al., 2011). The mean±SD clinical symptom scores were as follows: SAPS total=25.26±29.87; SANS total=24.5±13.05. Mean±SD illness duration of the sample was 37.11±35.73 months (median=33).
A significant positive correlation was seen between serum vitamin D
Discussion
In this study, 97% of antipsychotic-naïve or antipsychotic-free schizophrenia patients had sub-optimal (83%, deficiency; 14%, insufficiency) levels of serum vitamin D. The serum levels of vitamin D observed in our patients (14.5±5.7 ng/ml) add to the existing evidence of vitamin D deficiency in schizophrenia (Graham et al., 2014, Itzhaky et al., 2012). A novel observation in our study was the significant positive correlation between serum vitamin D level and right hippocampal GM volume. We
Acknowledgments
This work is supported by the CEIB Programme Support Grant to G.V. (BT/PR5322/COE/34/8/2012). V.S. & B.J. are supported by Department of Biotechnology, Government of India. S.V.K., A.C.A. & S.M.A. are supported by the Wellcome Trust/DBT India Alliance. J.C.N. is supported by the INSPIRE faculty; award by the Department of Science and Technology, Government of India. D.J. is supported by the Department of Science and Technology, Government of India.
References (49)
A fast diffeomorphic image registration algorithm
Neuroimage
(2007)- et al.
Unified segmentation
Neuroimage
(2005) - et al.
Vitamin D and psychosis: mini meta-analysis
Schizophr. Res.
(2013) - et al.
Neurotrophins and schizophrenia
Schizophr. Res.
(2007) - et al.
Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association
Schizophrenia Research
(2014) - et al.
Proline-induced inhibition of glutamate release in hippocampal area CA1
Brain Res.
(1997) - et al.
Vitamin D3 and brain development
Neuroscience
(2003) - et al.
Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain
J. Chem. Neuroanat.
(2005) - et al.
1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis
Mol. Brain Res.
(1997) - et al.
New clues about vitamin D functions in the nervous system
Trends Endocrinol. Metab.
(2002)
Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis
J. Steroid Biochem. Mol. Biol.
The molecular genetics of the 22q11-associated schizophrenia
Mol. Brain Res.
Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats
Neurobiol. Aging
Evidence of functional vitamin D receptors in rat hippocampus
Neuroscience
An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets
Neuroimage
Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study
Schizophr. Res.
Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects
Biol. Psychiatry
1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor
Mol. Brain Res.
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain
Neuroimage
Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats
Brain Res.
Free radicals, antioxidant defense systems, and schizophrenia
Prog. Neuro-psychopharmacol. Biol. Psychiatry
Seasonal changes in vitamin D status among Danish adolescent girls and elderly women: the influence of sun exposure and vitamin D intake
Eur. J. Clin. Nutr.
The Scale for the Assessment of Negative Symptoms
The Scale for the Assessment of Positive Symptoms
Cited by (36)
The association between vitamin D and symptom domains in psychotic disorders: A systematic review
2021, Schizophrenia ResearchCitation Excerpt :It is hypothesised that such changes are due to the interaction between vitamin D and dopamine neurons in the developing brain (Cui et al., 2021). Vitamin D deficiency is also associated with regions of the brain involved in the pathogenesis of psychotic disorders, including dysfunction of the hippocampus (Shivakumar et al., 2015), as well as with the levels of certain inflammatory markers found in chronic psychotic disorders (Chiang et al., 2016). Furthermore, preclinical studies have indicated that adult vitamin D deficiency may further impair cognitive function through its interactions with excitatory and inhibitory neurocircuits (Cui et al., 2021).
Associations of vitamin D deficiency with MRI markers of brain health in a community sample
2021, Clinical NutritionInflammatory biomarkers in psychosis and clinical high risk populations
2019, Schizophrenia ResearchCitation Excerpt :In immune-mediated conditions such as multiple sclerosis and Crohn's disease, high IL-6 levels have been linked to nutritional factors such as vitamin D deficiency, and have been shown to influence clinical status (Reich et al., 2016). Vitamin D has been found to be deficient in patients with schizophrenia (Graham et al., 2015) and linked to reduced hippocampal volume (Shivakumar et al., 2015). Vitamin D is a modulator of the immune system, and controls the development of the largest immune organ, gut-associated lymphoid tissue (GALT) (Weiss, 2011).
Neurobiological meaning of omega-3 fatty acids and their potential role in the treatment of schizophrenia
2019, Omega Fatty Acids in Brain and Neurological HealthHypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.
2018, Psychiatry ResearchCitation Excerpt :Patients with SZ are at higher risk of hypovitaminosis D (Belvederi Murri et al., 2013) and this association has been replicated in first episode psychosis in another recent meta-analysis (Firth et al., 2017) (for review see (Adamson et al., 2017)). Vitamin D deficiency may play a role in mediating hippocampal volume deficits, possibly through neurotrophic, neuroimmunomodulatory and glutamatergic effects (Shivakumar et al., 2015). A study has found high levels of hypovitaminosis in a monocentric sample of SZ inpatients in the south of France (Belzeaux et al., 2015) but no data is available to date in a national non-selected sample of community-dwelling SZ subjects.
Hippocampus volume reduction in psychosis spectrum could be ameliorated by vitamin D
2018, Schizophrenia Research